Global Doxorubicin Hydrochloride Liposome Injection Market to Reach USD 2.9 Billion by 2034 According to a newly published market research report by 24LifeSciences, the global doxorubicin hydrochloride liposome injection market was valued at USD 1.8 billion in 2025 and is projected to reach USD 2.9 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 2026–2034. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/14612/doxorubicin-hydrochloride-liposome-injection-market